Technology

59675 readers

3295 users here now

This is a most excellent place for technology news and articles.

Our Rules

Follow the lemmy.world rules.
Only tech related content.
Be excellent to each another!
Mod approved content bots can post up to 10 articles per day.
Threads asking for personal tech support may be deleted.
Politics threads may be removed.
No memes allowed as posts, OK to post as comments.
Only approved bots from the list below, to ask if your bot can be added please contact us.
Check for duplicates before posting, duplicates may be removed

Approved Bots

founded 1 year ago

MODERATORS

[email protected]

429

Masimo — the company that got the Apple Watch banned — has unveiled its new smartwatch (www.tomsguide.com)

submitted 10 months ago by [email protected] to c/[email protected]

155 comments fedilink hide all child comments

Masimo, the company that sued Apple over patent infringement, has unveiled its own blood oxygen monitoring smartwatch called the Masimo Freedom.
The Masimo Freedom is a health-focused device that can track blood oxygen levels, hydration index, respiration rate, pulse rate variability, pulse rate, steps, and detect falls.
The smartwatch is currently in prototype stage and will be available for sale later this year at a price of $999.

Archive link: https://archive.ph/aOUXX

you are viewing a single comment's thread
view the rest of the comments

[–] [email protected] 123 points 10 months ago (3 children)

I feel like they’d have made more money by licensing their patent to Apple rather than trying to sell a watch for a ridiculous $999 price tag. I’m not saying they were wrong for their patent lawsuit, and it’s nice to see that small companies can still win, but I just don’t see this early product getting enough sales for them to profit.

[–] [email protected] 95 points 10 months ago (1 children)

I might be mistaken, but I think Apple started with a licensing deal and then walked back on it?

Googled and found this

https://news.ycombinator.com/item?id=38774769

[–] [email protected] 26 points 10 months ago

Ahh, fair enough. Missed that bit

[–] [email protected] 15 points 10 months ago (1 children)

Nobody is buying this and I don't think they are trying very hard to sell it either. Notice that this pricing is only in the U.S. This seems like a ploy to bolster their case for damages and/or royalties in a settlement. Or maybe just part of their patent defense strategy. This company is primarily in medical tech. Even if they aren't so interested in the consumer market, they have to protect their patent or someone in a market they do care about will get away with it too. I would assume it strengthens their case if they can demonstrate material damages in a market they participate in. So quickly unveil a prototype, price it so there's little to no demand, don't bother manufacturing a product nobody wants, win the case, cancel the product.

[–] [email protected] 2 points 10 months ago

Hmm, that’s a new theory I haven’t heard. It sounds pretty plausible so I’ll be interested to see if it plays out like that.

[–] [email protected] 1 points 10 months ago

I’m definitely curious about the history here, since it seems like Apple would have easily been able to offer more than they can benefit here. Who did what and when? Who tried to compromise with what and who rejected it?

From the PR side, Apple seems reasonable and has a good explanation, but clearly the court did not find their arguments convincing

I don’t know if there are sources I’m not finding, but a lot of people here are very confidently stating as facts, things I don’t see any source for so may be based on irrational hatred of a consumer products company